Placeholder Banner

BIO Presents the Henri A. Termeer Biotechnology Visionary Award to Gates Foundation’s Dr. Sue Desmond-Hellmann

June 6, 2018
Media Contact
Theresa Brady

Washington, D.C. (June 6, 2018) – The Biotechnology Innovation Organization (BIO) is pleased to announce the establishment of the Henri A. Termeer Biotechnology Visionary Award – created in honor of the late Genzyme CEO who was instrumental in transforming Boston into a thriving hub of life science research, development and innovation. 

The award was presented today in Boston at the 2018 BIO International Convention to Dr. Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation, to recognize her innovative accomplishments in cancer and infectious disease treatment. As a pioneer in healthcare for more than 30 years – and a “hero to legions of cancer patients” as reported by Forbes in 2009 – Dr. Desmond-Hellmann has devoted her career to eradicating disease, poverty and inequity.

“It is only fitting that an award to honor our dear friend and role model, Henri Termeer, be given to Dr. Sue Desmond-Hellmann – a visionary leader whose work has helped millions,” said Jim Greenwood, President and CEO of BIO. “We’re proud to honor his profound impact by recognizing her dedication to patient care and enthusiasm for innovation – traits that Henri held dear.”

Termeer’s lifelong commitment to the industry contributed not only to his lasting success, but his respect as a leader, entrepreneur, innovator, mentor and businessman. His accomplishments were admirable and extensive, from the creation of Genzyme to his leadership in the orphan rare disease community.

From this year forward, BIO will recognize one individual annually who reflects the leader’s innovative spirit and transformative impact on patient lives. 

Follow the BIO 2018 Convention @BIOConvention and join the conversation @IAmBIOtech.


About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.


Upcoming BIO Events

BIO World Congress on Industrial Biotechnology
July 16-19, 2018
Philadelphia, PA

BIO Latin America Conference
September 4-5, 2018
Sao Paulo, Brazil

BIO Investor Forum
October 17-18, 2018
San Francisco

BIO Patient and Health Advocacy Summit
October 25-26, 2018
Washington, DC

Discover More
Today more than 20 leading biopharmaceutical companies announced the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as the threat of antimicrobial resistance, or…
Washington, D.C. (July 8, 2020)—The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO IMPACT Ag &…
Congressional Action Plan Released Today Incorporates Key BIO Recommendations Washington, D.C. (June 30, 2020) – Cleaner air, healthier soils, and improved human health – goals of a Congressional climate crisis action plan released today – are just…